Nasonex (Mometasone Furoate)

Mometasone furoate is a selective glucocorticoid receptor agonist. When applied to the nasal mucosa, it binds intracellular receptors, suppresses the production of inflammatory cytokines, and inhibits activation and migration of immune cells, thereby decreasing swelling and mucus production in the nose.

The specific dose of Nasonex is determined by the prescribing healthcare professional based on the patient’s age, condition severity, and response to therapy. Patients should follow the prescriber’s instructions and not adjust the number of sprays without medical guidance.

Safety data for Nasonex in pregnancy and lactation are limited. Women who are pregnant, planning to become pregnant, or breastfeeding should discuss potential risks and benefits with their healthcare provider before using the medication.

To request Nasonex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Nasonex contains mometasone furoate, a potent corticosteroid with high topical activity and low systemic absorption. Compared with older nasal steroids such as beclomethasone, it often provides effective symptom control at lower spray volumes, but choice of therapy should be individualized by the prescriber.

Nasonex should be stored at room temperature, away from direct heat and moisture. Keep the spray in its original packaging, ensure the cap is tightly closed, and avoid exposing it to extreme temperatures to maintain product stability.

Nasonex is administered as a nasal spray. The patient gently shakes the bottle, primes it if required, tilts the head slightly forward, inserts the nozzle into one nostril, and sprays the prescribed number of actuations while breathing in gently. The process is repeated in the other nostril if directed.

Serious risks, though uncommon, include nasal septal perforation, severe allergic reactions such as anaphylaxis, vision changes, cataract formation, adrenal suppression with prolonged high‑dose use, and opportunistic fungal infections of the nasal cavity. Patients should seek immediate medical attention if these occur.

Nasonex is contraindicated in individuals with known hypersensitivity to mometasone furoate or any component of the formulation. It should also be avoided in patients with untreated bacterial, fungal, or viral nasal infections until the infection is resolved.